Additional information: fda site id, mfr site id, patient code: c64343(decreased hemoglobin, decreased urine output, tense abdomen, open lesion).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after implant, the patient experienced decreased hemoglobin, chelonae causing wound infection, mesh coated with purulent material, increased respiratory distress, decreased urine output, tense abdomen, dilated bowel and roux limb, clot inright flank and into the pelvis, the two pieces of mesh were more tense, large abdominal open wound with continued drainage, exposed mesh, weakness, weight loss, infected mesh, punctate opening, open lesion, loosening of mesh, and extruding mesh.Post-operative patient treatment included returned to or, ng tube placed to evacuate excess air and fluid from colon, small bowel and stomach, staples and sutures removed to expose the mesh base, mesh was cut side to side and closed again with suture, presented to ed, hospitalized for one month, iv antibiotics, picc line, wound repacked, scheduled dressing changes, potassium repletion, aggressive irrigation of the wound, iv fluids, revision surgery, hernia repair with new mesh, and mesh removal.
|